The FDA approval will enable the BCI platform to support more internet-connected personal devices including laptops, tablets and phones.
Paradromics Inc., a leader in neurotechnology and developer of the world's highest-data-rate brain-computer interface platform, today announced that it has received an approval letter from the U.S.